fda semaglutide ruling free to pursue compounders after latest court What Changed? The FDA's Clarification

Ongoing Monitoring: Regular follow-ups to track your progress, address any side effects, and adjust your treatment plan as necessary

*Compounded formulations of GLP-1s are not reviewed by the FDA for safety, efficacy, or quality

Expanding coverage of anti-obesity interventions to eligible individuals could generate billions of budgetary savings to the Medicare budget [48]

Is it safe to donate blood if youre on a GLP-1 drug like Ozempic, Mounjaro or Zepbound

This is despite FDAs prior correspondence with Novo Nordisk about promotional communications that date back as far as 2010 (for Victoza)

Results May Vary: Individual results will vary based on factors including age, baseline health condition, starting weight, diet, exercise, consistency with treatment, genetic factors, current medications, and other individual variables